DOCSLIB.ORG

Astrazeneca-Oxford Vaccine Approved for Use in the U.K

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Astrazeneca-Oxford Vaccine Approved for Use in the U.K P2JW366000-6-A00100-17FFFF5178F ****** THURSDAY,DECEMBER 31,2020~VOL. CCLXXVI NO.154 WSJ.com HHHH $4.00 DJIA 30409.56 À 73.89 0.2% NASDAQ 12870.00 À 0.2% STOXX 600 400.25 g 0.3% 10-YR. TREAS. À 3/32 , yield 0.926% OIL $48.40 À $0.40 GOLD $1,891.00 À $10.50 EURO $1.2300 YEN 103.21 Deadly Attack at Airport Targets New Yemen Government U.S. IPO What’s News Market Reaches Business&Finance Record nvestorspiled into IPOs Iat a record rate in 2020, with companies raising Total $167.2 billion via 454 of- ferings on U.S. exchanges this year through Dec. 24. Few see signs of letup Few expect the euphoria after companies raise to wear off soon. A1 more than $167 billion Detenteisending in the global fight over tech taxes, despite pandemic with Franceresuming collec- tion of itsdigital-services tax BY MAUREEN FARRELL and the U.S. poised to retali- atewith tariffs.Other coun- Defying expectations,inves- tries areset to join the fray. A1 S tors piled intoinitial public of- China finished 2020 PRES feringsatarecordrateiN with a 10th consecutive TED 2020, and few expect the eu- month of expansion in its CIA phoria to wear off soon. manufacturing sector. A7 SO Companies raised $167.2 AS TheEUand China agreed TENSIONS HIGH: People fled after an explosion Wednesday at the airport in Aden, Yemen, moments after members of the billion through 454 offerings in principle on an invest- country’s newly sworn-in cabinet arrived. At least 22 people were killed, but all the members of the cabinet were safe. A16 on U.S. exchanges this year ment accord that has sowed through Dec.24, compared concern in Washington. A16 with the previous full-year re- cord of $107.9 billion at the Alden Global Capital,the height of the dot-com boom in largest shareholder in Trib- 1999, according to Dealogic. une Publishing,isseeking AstraZeneca-Oxford Vaccine Thepandemic turned the to buy the newspaper chain, typical rhythm of the IPO mar- which has amarket value of ketonits head, with $67.3 bil- roughly $470 million. B1 lion raised in the fourth quar- SoftBank agreed to invest Approved for Use in the U.K. ter. That amount is roughly six $200 million more to bail times the totalfor the first out Katerra, a construction three months of the year. startup that ranintofinancial As aresult of the scramble, problems as it tried to shake BY JOSEPH WALKER inoculationstoreach more billion doses available in Advancemarket stalwartsofthe 21st-century up the building industry. B1 AND JENNY STRASBURG people morequickly as the 2021—morethan anyother commitments of vaccine economyincluding Airbnb variant pushes newcases to Covid-19 vaccine maker—and Inc., DoorDash Inc.and Palan- TheDow rose 0.2%, doses by countryincome LONDON—TheU.K.autho- recordsand hospitalizations at acheaper price. TheU.K. tir Technologies Inc. are now clinching its13th record rized aCovid-19 vaccine devel- soar. companysays it won’t profit 3.0 billion publicly traded, accessible to close of the year.The S&P COVAX* oped by the University of Ox- Thegreen light represents from the shot during the pan- the average investor. 500 and Nasdaq added 0.1% ford and AstraZenecaPLC, thethirdemergency-use ap- demic,oreverinthe case of 2.5 Low- or medium- When the pandemic began and 0.2%, respectively. B9 income country opening the door fordistribut- proval of aWestern-devel- poorer countries. 2.0 shutting down swaths of the Amazon said it agreed to ing millions of doses in acoun- oped vaccine this month and Thevaccine canbetrans- High-income U.S. economyinMarch and country acquirepodcast producer trywhereamoreinfectious comes as cases rise sharply in ported and stored for months 1.5 the stockmarket swooned, Wondery, the online retail variant of the coronavirus has Europe and the U.S.,which re- with normal refrigeration, veteranIPO watchersbraced giant’slatestmovetobeef contributed to surging cases. ported itsfirst confirmed case making it easier to distribute 1.0 foranother disappointing year up itsaudio offerings. B1 British health officials also of the variant Tuesday. The where people and health-care 0.5 afteractivity in 2019 fell short recommended adelayofas Pfizer-BioNTech shot and one networks aresparse or under- of expectations. World-Wide long as three months between developed by Moderna Inc. funded. Thetwo other West- 0 Following abrief pause, both doses of the vaccine, have been cleared in the U.S. PleaseturntopageA6 AstraZeneca/ Pfizer/ Moderna new-issue activity resumed in guidancethat applies to the TheOxford-AstraZeneca Oxford BioNTech late Mayafter the Federal Re- shot developed by Pfizer Inc. vaccine stands out on price, New variant of virus pops up servesignaled it would take The U.K. authorized a *A global buying club comprising both high- Covid-19 vaccine developed and BioNTech SE that the U.K. convenience and global ambi- in California, Colorado........... A3 and low-income countries extraordinarymeasures to by the University of Oxford authorized earlier in the tion.AstraZenecahas prom- China gives green light to Note:DataasofDec. 18 shoreupthe economy, and the and AstraZeneca, opening month.The delaywill allow ised to makeasmanyasthree Covid-19 vaccine....................... A7 Source:DukeGlobal Health Innovation Center stock market rebounded. the door for the rollout of Several stocks that made millions of doses. But the their debutsaround then clearancecomes afterstum- soared, setting the stagefor a bles that have sown public Rocky Partnership Hobbles Rollout race to the public marketsthat doubt about the shot and afterabrief holidaypause is strained the partnership. A1 expected to pick up again in California became the BY JENNY STRASBURG cine watchdogsinthe U.S. and to showtothe Food and Drug tious project. In lateNovem- the new year. second state in the U.S. to elsewhere that their missteps Administration by February, ber,they unveiled late-stage TheIPO market gotaboost confirm the presence of LONDON—TheU.K.’sautho- arebehind them and that their said aperson familiar with the trial resultsthat showeda from asurprising surge in spe- the fast-spreading corona- rization of a Covid-19 vaccine vaccine,while not as effective trial. Thepartnershope for wide range of efficacy levels, cial-purpose acquisition com- virus variant that was first developed by the University of as shotsfromtwo rivals al- authorization acrossEurope varying by dose and age panies,orSPACs,empty vehi- identified in the U.K. A3 Oxfordand AstraZenecaPLC ready rolling out, canplaya by February, and agreen light group.The presentation de- cles that raise money through marks ahome-turfvictoryfor meaningfulrole in curbing the in Australia could come soon, scribed an unusual and unex- listingsand then look forbusi- Theprospect of quick Sen- the two British institutions pandemic. this person said. AstraZeneca’s pected half dose given to some nesses to merge with. They ateapproval of $2,000 stimu- but comes afterstumbles that Thepartnershavepromised manufacturing partner in In- subjectsthat wasn’t fully ex- represent a bet that a yet-un- lus checks dimmed further, have sown public doubt about to distributetheir vaccine in dia has asked forregulatory plained, sowing confusion and known business will generate with the chamber focused on the shot and strained the part- hugequantities and sell it authorization there. All de- skepticism about the vaccine. steepreturns and typifythe overriding Trump’s defense- nership itself. cheaply throughout the pan- pend on regulatory sign-off. U.K. regulatorsonWednes- risk appetite that is fueling bill veto and GOP leaders After clearing regulatorsat demic.Inthe U.S.,AstraZen- Complicating those plans daypraised the vaccine’s new issues and markets. opposing astand-alone vote home,the partnersfacethe ecaexpectstohavedatafrom aredoubtsseeded by the part- promise to help end the pan- Nearly half of all fundrais- on the largerpayments. A4 challengeofconvincing medi- a large American clinical trial ners’ handling of their ambi- PleaseturntopageA6 PleaseturntopageA2 Nashville policesaid that they repeatedly tried to reach the suspect in the city’s The Optimists Christmas Day bombing INSIDE FranceRevives Fight soon afterbeing told in 2019 that he wasmaking bombs Plan Their inside an RV at hishome. A3 Over Digital Taxes AChinese court sentenced Vacations to prison 10 Hong Kong ac- iii BY SAM SCHECHNER Other countries,including Italy tivistswho were caught AND PAUl HANNON and the U.K.,whose similar fleeing the city on aspeed- Cabin fever taxeswent intoeffect this year, boat, acase that has drawN Detenteisending in the arealso set to begin collection international attention. A8 inspires big travel global fight over tech taxes. in coming months. LawmakersinArgentina Earlier this year, France TheU.S., meanwhile,isset approved a bill to legalize dreams for 2021 agreed to suspend collection of on Jan. 6 to impose tariffs on abortion, making it the /REUTERS atax on digital revenue from $1.3 billion of French imports, BY ALINA DIZIK /NETFLIX largetechnologycompanies including cosmetics and hand- AY first large Latin American LANG BR country to ditch stringent ES such as Facebook Inc., Ama- bags. Washingtonalso has Jocelyn Kung hasn’t gotten zon.comInc.and Alphabet pending investigations that JAM antiabortion regulations. A16 PHIL the Covid-19 vaccine yet, but Inc.’sGoogle.Meanwhile,the could lead to similar tariffs on Died: Howard Rubenstein, she already is planning fora SPORTS BUSINESS&FINANCE U.S. delayedthe application of 10 other countries,including 88,influential publicist. B1 grand getaway onceshe does. Alabama, Clemson, The streaming wars tariffs it wasputting on French the U.K.,Italy,India and Spain. The62-year-old executive Ohio Stateand Notre of 2020 turned goods in retaliation forthe tax. At issue in the disputeis coach from SanFranciscosays But nowFrancehas re- PleaseturntopageA4 NOTICE TO READERS she is splurging on athree- Dame continue to into afeast as sumed collecting what is WSJ.comand WSJmobile week,seven-stop“transforma- dominate. A12 subscriberssoared. B1 known as itsdigital-services European companies seek apps will publish tional experience” in Vietnam tax, aFrench official said.
Load more

Recommended publications
  • Old Road Campus
    Old Road Campus 4a, 4b, 4c, U5 n o t Oxford City Centre g OLD ROAD n i d 4a, 4b, 4c, U5 a e H K O L L A D R O W AD E M I L 4,4a,4b,4c, U1X,U5 A41 42 4,4a,4b,4c,U5 Rin D 4 g R oad 6 7 1 13 3 11 C H U R C H I L L 900 D 2 R I 700, 900 V E E O x f o 5 A C rd 12 C i ty 10 C e n t re B 8 CAR PARK C 9 h u r c R F h i O l l O S H E o V s N E p L i T t DRI a VE ENTRANCE ROOSEVELT DRIVE l 900, ST2 Index 1 The Triangle Nursery 9 Old Road Campus Estates Annexe 13 Boundary Brook House Interserve Joint Research Office Kennedy Institute 2 - Research Services, Medical Sciences Division Old Road Campus Research Building 10 - Clinical Trials and Research Governance 3 New Richards Building Department of Oncology - Human Tissue Governance CRUK/MRC Oxford Institute for Radiation Oncology - Medical Sciences Division Business Development 4 NDM Research Building Institute of Biomedical Engineering Nuffield Department of Primary Care Health Sciences Target Discovery Institute Jenner Institute Medical Sciences Divisional Safety Officers Centre for Tropical Medicine and Global Health Bodleian Knowledge Centre (Library Services) Medical Sciences Division IT Services 5 Wellcome Centre for Human Genetics (WHG) Ludwig Institute for Cancer Research Structural Genomics Consortium 6 Henry Wellcome Building for Molecular Physiology Nuffield Department of Surgical Sciences Loading Bays and Delivery Offices of the Nuffield Professor of Medicine ENTRANCE VIA BUILDING 5 11 Big Data Institute A Wellcome Trust Centre for Human Genetics 7 Henry Wellcome Building for Particle Imaging
    [Show full text]
  • Conference Program Table of Contents Agenda 3 Conference Chairs 12 Moderators & Speakers 14 Our Partners 42 Exhibitors 44
    AIMSE 2017 Fall Conference October 11–12 Princeton Club New York CONFERENCE PROGRAM TABLE OF CONTENTS AGENDA 3 CONFERENCE CHAIRS 12 MODERATORS & SPEAKERS 14 OUR PARTNERS 42 EXHIBITORS 44 As a participant in the CFA Institute Approved-Provider Program, AIMSE has determined that this program qualifies for 5 credit hours. If you are a CFA Institute member, credit for your participation in this program will automatically be recorded in your CE tracking tool. AGENDA OCTOBER 11, 2017 12:00 pm – 6:00 pm Registration 1:15 – 1:30 pm Welcome Remarks James Madison Room CONFERENCE CO-CHAIRS Tim Hill Vice President, Sales & Marketing Q- Emerging Markets Corp. Michael Gillis Senior Vice President, Business Development Greystone Managed Investments, Inc. AIMSE PRESIDENT Carolyn Patton, CFA Head of Distribution Americas First State Investments 1:30 – 2:10 pm What’s Going On? James Madison Room To kick off the conference we will hear from leading industry thinkers about the state of the industry today and where it is headed tomorrow. What are investors thinking given the ever-changing global investment landscape and how will that lead to changes in portfolio allocations? MODERATOR Bart Marchant Institutional Regional Director, Southeast WisdomTree Asset Management SPEAKERS Safia Mehta, CFA Senior Vice President, Portfolio Manager Progress Investment Management Company, LLC Timothy Ng Chief Investment Officer Clearbrook Timothy Taylor Senior Investment Officer, Global Equity Florida State Board of Administration Mark Yusko Chief Executive Officer & Chief Investment Officer Morgan Creek Capital Management 3 2:15 – 3:10 pm New York State of Mind James Madison Room With over a trillion dollars of investable assets in pension plans, endowments, foundations and family offices, the State of New York is home to one of the largest pools of capital available to investment managers.
    [Show full text]
  • Unisys Company Overview Disclaimer
    Unisys Company Overview Disclaimer • This presentation includes certain financial measures not presented in accordance with U.S. generally accepted accounting principles (“GAAP”), including, but not limited to, EBITDA, Adjusted EBITDA, Free Cash Flow, Adjusted Free Cash Flow, and constant currency, and certain ratios and other metrics derived therefrom. These non-GAAP financial measures are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing the Company’s financial results. • Therefore, these measures should not be considered in isolation or as an alternative to cash flows from operations or other measures of profitability, liquidity or performance under GAAP. You should be aware that the Company’s presentation of these measures may not be comparable to similarly-titled measures used by other companies. Reconciliations of all non-GAAP financial measures are available in this presentation. © 2016 Unisys Corporation. All rights reserved. 2 Unisys at a Glance >1,500 >20,000 130+ $3.0B Global clients Associates Countries 2015 globally served revenue >60 million air cargo 300 government transactions per agencies worldwide month More than 90 of the Fortune Global 500 companies Over half of the top 25 global banks and 18 of the top 25 Building one of the 10 of the world’s global airlines largest cloud-based, on top insurance demand U.S. state companies government computing environments © 2016 Unisys Corporation | All rights reserved. 3 Key Company Highlights 1 Diversified Revenue Model 2 Long-Standing Relationships with Blue-chip Client Base 3 Leading-Edge Technological Solutions 4 Recurring Service Revenue with Large Contractual Backlog 5 Financial Progress 6 Experienced Management Team © 2016 Unisys Corporation.
    [Show full text]
  • In the United States District Court for the District Of
    IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABORATORIES, LLC and ) FOREST LABORATORIES ) HOLDINGS, LTD., ) ) Plaintiffs, ) ) v. ) Civ.No.14-1119-SLR ) SIGMAPHARM LABORATORIES, LLC, ) et al., ) ) Defendants. ) Jack B. Blumenfeld, Esquire and Maryellen Noreika, Esquire of Morris, Nichols, Arsht & Tunnell LLP, Wilmington, Delaware. Counsel for Plaintiffs. Of Counsel: Howard W. Levine, Esquire, Sanya Sukduang, Esquire, Jonathan R. Davies, Esquire, Courtney B. Gasp, Esquire, and Charles E. Lipsey, Esquire of Finnegan, Henderson, Farabow, Garrett & Dunner LLP. John C. Phillips, Esquire, David A. Bilson, Esquire and Megan C. Haney of Phillips, Goldman, Mclaughlin & Hall, P.A., Wilmington, Delaware. Counsel for Defendant Sigmapharm Laboratories, LLC. Of Counsel: Anthony G. Simon, Esquire, Anthony R. Friedman, Esquire, Benjamin R. Askew, Esquire, and Michael P. Kella, Esquire of The Simon Law Firm, P.C. Karen Elizabeth Keller, Esquire and Jeffrey Thomas Castellano, Esquire of Shaw Keller, LLP, Wilmington, Delaware. Counsel for Defendants Hikma Pharmaceuticals LLC, Hikma Pharmaceuticals PLC, and West-Ward Pharmaceutical Corp. Of Counsel: lmron T. Aly, Esquire, Joel M. Wallace, Esquire, and Helen H. Ji, Esquire of Schiff Hardin LLP. Richard D. Kirk, Esquire, Stephen B. Brauerman, Esquire and Sara E. Bussiere, Esquire of Bayard, P.A., Wilmington, Delaware. Counsel for Defendant Breckenridge Pharmaceutical, Inc. Of Counsel: Beth D. Jacob, Esquire, Clifford Katz, Esquire, and Malavika A. Rao, Esquire of Kelley, Drye & Warren LLP. Karen Pascale, Esquire and Pilar G. Kraman, Esquire of Young, Conaway, Stargatt & Taylor, LLP, Wilmington, Delaware. Counsel for Defendants Alembic Pharmaceuticals Ltd., Alembic Global Holding SA and Alembic Pharmaceuticals, Inc. Of Counsel: Steven J. Lee, Esquire, Michael K.
    [Show full text]
  • Preclinical Development & IND Filing: Nuts, Bolts, Best Practices
    “Preclinical Development & IND Filing: Nuts, Bolts, Best Practices and Regulatory Aspects.” Speakers: Amit Kalgutkar (Pfizer), Chandra Prakash (Agios), Sanjeev Thohan (Novartis), Li- Chun Wang (Takeda), Wei Yin (Biogen) Organizers: Sanjeev Thohan and Chandra Prakash Date: 6/29/2017 Time: 8:30 am – 5.00 pm Location: Boston/Cambridge Area: Marriott Kendall Square, 50 Broadway, Cambridge MA 02142 Fees: $175 - Regular (before June 1st, 2017), $225 - Regular (after June 1st, 2017); $125 - Unemployed & Academic; $2000 - Major Sponsorship; $475 - Vendor Show Registration: www.PBSS.org Workshop Description: An investigational new drug application (IND) is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations and processes of assembling an IND is a key to not only successful filing, but also a promising clinical development path forward. Often there are cases where too many of our “nice-to-have” studies crowd the package at the expense of critical study needs/issues. This can lead to significant delays in clinical developments with back-and-forth of Q&A sessions both internally and with regulatory agencies. As we have seen, the regulatory landscape is changing as rapidly as the industry innovates into new therapeutic modalities. Therefore, it is critical to keep up to date on regulatory requirements and the industry’s best practices in different aspects of the IND: non- clinical safety, PK, CMC, and clinical plans. In this workshop, our speakers who bring years of experience with multiple successful IND filings, will discuss systematically the preclinical studies required for small molecule IND’s as well as the nuts and bolts of putting together a high–quality IND package.
    [Show full text]
  • Assessment Report COVID-19 Vaccine Astrazeneca EMA/94907/2021
    29 January 2021 EMA/94907/2021 Committee for Medicinal Products for Human Use (CHMP) Assessment report COVID-19 Vaccine AstraZeneca Common name: COVID-19 Vaccine (ChAdOx1-S [recombinant]) Procedure No. EMEA/H/C/005675/0000 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 An agency of the European Union © European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged. Table of contents 1. Background information on the procedure .............................................. 7 1.1. Submission of the dossier ..................................................................................... 7 1.2. Steps taken for the assessment of the product ........................................................ 9 2. Scientific discussion .............................................................................. 12 2.1. Problem statement ............................................................................................. 12 2.1.1. Disease or condition ........................................................................................ 12 2.1.2. Epidemiology and risk factors ........................................................................... 12 2.1.3. Aetiology and pathogenesis .............................................................................
    [Show full text]
  • Cynthia Kyriazis Is a Productivity Strategist, Organization Consultant, Time Management Coach, Speaker, and Author
    Cynthia Kyriazis is a productivity strategist, organization consultant, time management coach, speaker, and author. She leads decision-makers, their teams, and staff in navigating the 24/7 demands on their time and energy by developing a clear line of sight on what’s important and a plan for how to get there. 80% of Cynthia’s clients report saving at least 45 minutes a day in real time and 91% have improved their overall productivity. Cynthia possesses a 20-year track record of success in serving Fortune 500 companies, entrepreneurial businesses, government, and non-profit agencies. Regardless of the organization size, Cynthia guides leaders and Cynthia star performers to make choices that create and sustain a productive kyriazis mindset, and positively impact both personal growth and organizational profitability. Cynthia is the Amazon best-selling author of Get Organized. Get Focused. Get Productivity Moving. How to Overcome Productivity Potholes. She has also been featured & Organization as an expert on Forbes.com, Wall Street Journal online, the Philadelphia Consultant Inquirer, Legal Intelligencer, and many regional publications, radio, and television shows – and was named one of the “28 Best Online Productivity Experts” by New York Times best-selling author Hank Reardon in his book Time Management 2.0. Organizations Qualifications & Education We Have Served • Past-Secretary to the National Association of Professional Organizers (NAPO) • American Diabetes Association • Past-President of the Kansas City chapter of the International Society for • Avery Dennison Performance Improvement (KC-ISPI) • Bayer HealthCare • Consultant to the American Coaching Association • Campbell Soup Company • Certified Professional Behavioral Analyst (CPBA) • Cerner • Certified Professional Values Analyst (CPVA) • Cisco • B.S., Communication, University of Kansas • Coca Cola Bottling • Eli Lily Endorsements • GlaxoSmithKline • G.E.
    [Show full text]
  • Annual Meeting
    Volume 97 | Number 5 Volume VOLUME 97 NOVEMBER 2017 NUMBER 5 SUPPLEMENT SIXTY-SIXTH ANNUAL MEETING November 5–9, 2017 The Baltimore Convention Center | Baltimore, Maryland USA The American Journal of Tropical Medicine and Hygiene The American Journal of Tropical astmh.org ajtmh.org #TropMed17 Supplement to The American Journal of Tropical Medicine and Hygiene ASTMH FP Cover 17.indd 1-3 10/11/17 1:48 PM Welcome to TropMed17, our yearly assembly for stimulating research, clinical advances, special lectures, guests and bonus events. Our keynote speaker this year is Dr. Paul Farmer, Co-founder and Chief Strategist of Partners In Health (PIH). In addition, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, will deliver a plenary session Thursday, November 9. Other highlighted speakers include Dr. Scott O’Neill, who will deliver the Fred L. Soper Lecture; Dr. Claudio F. Lanata, the Vincenzo Marcolongo Memorial Lecture; and Dr. Jane Cardosa, the Commemorative Fund Lecture. We are pleased to announce that this year’s offerings extend beyond communicating top-rated science to direct service to the global community and a number of novel events: • Get a Shot. Give a Shot.® Through Walgreens’ Get a Shot. Give a Shot.® campaign, you can not only receive your free flu shot, but also provide a lifesaving vaccine to a child in need via the UN Foundation’s Shot@Life campaign. • Under the Net. Walk in the shoes of a young girl living in a refugee camp through the virtual reality experience presented by UN Foundation’s Nothing But Nets campaign.
    [Show full text]
  • 03.031 Socc04 Final 2(R)
    STATEOF CENTER CITY 2008 Prepared by Center City District & Central Philadelphia Development Corporation May 2008 STATEOF CENTER CITY 2008 Center City District & Central Philadelphia Development Corporation 660 Chestnut Street Philadelphia PA, 19106 215.440.5500 www.CenterCityPhila.org TABLEOFCONTENTSCONTENTS INTRODUCTION 1 OFFICE MARKET 2 HEALTHCARE & EDUCATION 6 HOSPITALITY & TOURISM 10 ARTS & CULTURE 14 RETAIL MARKET 18 EMPLOYMENT 22 TRANSPORTATION & ACCESS 28 RESIDENTIAL MARKET 32 PARKS & RECREATION 36 CENTER CITY DISTRICT PERFORMANCE 38 CENTER CITY DEVELOPMENTS 44 ACKNOWLEDGEMENTS 48 Center City District & Central Philadelphia Development Corporation www.CenterCityPhila.org INTRODUCTION CENTER CITY PHILADELPHIA 2007 was a year of positive change in Center City. Even with the new Comcast Tower topping out at 975 feet, overall office occupancy still climbed to 89%, as the expansion of existing firms and several new arrivals downtown pushed Class A rents up 14%. For the first time in 15 years, Center City increased its share of regional office space. Healthcare and educational institutions continued to attract students, patients and research dollars to downtown, while elementary schools experienced strong demand from the growing number of families in Center City with children. The Pennsylvania Convention Center expansion commenced and plans advanced for new hotels, as occupancy and room rates steadily climbed. On Independence Mall, the National Museum of American Jewish History started construction, while the Barnes Foundation retained designers for a new home on the Benjamin Franklin Parkway. Housing prices remained strong, rents steadily climbed and rental vacancy rates dropped to 4.6%, as new residents continued to flock to Center City. While the average condo sold for $428,596, 115 units sold in 2007 for more than $1 million, double the number in 2006.
    [Show full text]
  • Jenner Institute Complementary Vaccines Platform Technologies
    WHO R&D Blueprint: Janssen Vaccines – Jenner Institute complementary Vaccines Platform Technologies Janssen Vaccines: Jenner Institute: Olga Popova Prof. Sarah Gilbert Jerome Custers WHO Geneva, 21 July 2016 Background • Jenner Institute & Janssen Vaccines presented respective proposals to WHO R&D Blueprint Workshop in April 2016, and were invited to join forces for Round 2 submission • Example of alignment, coordination and partnership between public and private sector stakeholders • Understanding nature of vaccine development, established complementary end‐to‐end skills and capabilities • Long‐term, sustainable & consistent approach and funding • High‐level flexible proposal with illustrative examples • «Bona fide»: collaborative framework to be developed JOINTLY TOWARDS TANGIBLE OUTCOMES x GLOBAL PUBLIC HEALTH 2 Success factors • Available platforms and previous experience with pathogens • Ability to invest time and resources, leverage expertise, minimise opportunity costs and ensure business continuity • Appropriate and functionable operational model, speed • Lean governance, partner alignment and milestone orientation INTERNAL • Reliable & qualified partners, durable commitments • Long‐term reliable funding (min 5‐year horizon) • Resolving vaccination indemnification / liability issue • Consistency in pathogen prioritisation and defined, consistent pre‐ established endpoint commitment • Clear and accelerated / streamlined regulatory pathways, conditions & predictability of licensure EXTERNAL • Anticipated deployment plans and community
    [Show full text]
  • Local Producers Sparkling Pinot Grigio & Sauvignon Blanc Riesling
    Wine List Local Producers 1 & 2 Sparkling 3 Pinot Grigio & Sauvignon Blanc 4 Riesling & Unique White Varietals 5 Chardonnay 6 Rose' 7 Pinot Noir & Spanish Reds 8 Italian Reds by Region 9 & 10 Merlot & Malbec 11 Red Blends by Region 12 & 13 Cabernet Sauvignon 14 Syrah/Shiraz & Zinfandel 15 Local Producers White Bellview Winery Traminette Landisville, NJ 8 30 Sharott Winery Vidal Blanc Hammonton, NJ 8 30 Sharott Winery Vignoles Hammonton, NJ 8 30 Amalthea's "Green Dragon" Chardonnay A tco, NJ 9 34 RED Amalthea Cellars Pinot Noir Hammonton, NJ 9 34 DiMatteo Vineyard "Pasquale Red" Hammonton, NJ 8 30 C oncord & Ives Plagido's Winery " Concetta's Casalinga" Hammonton, NJ 8 30 F ield B lend Bellview Winery Coeur D'Est Landisville, NJ 11 42 C ab ern et F ran c , C h am b o u rc in , M erlo t, & P etit V erd o t Valenzano Winery Malbec Shamong, NJ 10 38 Bellview Winery Cabernet Franc Landisville, NJ 11 42 Amalthea Cellars Legends Europa III A tco , NJ 11 42 C abernet Sauvignon, C abernet Franc, & M erlot Valenzano Winery Port Shamong, NJ 8 30 1 Local Producers Fruit (non-grape) DiMatteo Vineyard Blueberry Hammonton, NJ 8 30 Tomasello Winery Cranberry Hammonton, NJ 8 30 Tomasello Winery Cherry Hammonton, NJ 8 30 Tomasello Winery Pomegranate Hammonton, NJ 8 30 Tomasello Winery Sparkling Blueberry Hammonton, NJ 8 30 2 Sparkling Juame Serra Cristalino Brut Cava Penedes, Spai n NV 8 30 Tomasello Winery Sparkling Blueberry Hammonton, NJ NV 8 30 Lobetia Pink Bubbles L a M ancha, Spai n NV 8 30 O rganic, G arnacha & B obal House Prosecco V eneto, I tal y NV 9 34 Braida Moscato D'Asti Vigna S.N.
    [Show full text]
  • Totally Blank Broadsheet
    A8 • Adirondack Daily Enterprise • adirondackdailyenterprise.com • Wednesday, June 17, 2020 Want to see your sports news and photos in the Enterprise? Contact the sports department at 891-2600 ext. 26 Sports or [email protected] 19 students earn black belts as local school closes By LOU REUTER Senior Sports Writer SARANAC LAKE — Grand Master Jon O’Kelly’s final day of being a Taekwondo instructor was one of his most memorable ones. After a 35-year career of teaching the martial art, O’Kelly has retired. A Saranac Lake resident, O’Kelly opened the Northeast Taekwondo school in this village in Sept. 2016. On Saturday, he performed his final duty as the head of the school, pro - moting 19 local students to black belts during an outdoor ceremony held on the North Country Commu - nity College soccer field. O’Kelly said all 19 who were promoted were original students of the Saranac Lake-based school when it opened nearly four years ago, and the youngest new black belt earner was 9-year-old Cole Davide. The ceremony was held on a chilly, damp day with plenty of space between the students, who all wore matching black facemasks that included an image of a martial artist. The day began with testing and ended with the handing out of black belts and certificates. O’Kelly said Easton Crary is presented his black belt by Northeast Taek - he was especially impressed with wondo school instructor Grand Master Jon O’Kelly. the display by his students because the school has been shut down for itself.” he said.
    [Show full text]